Terms: = Lung cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Prognosis
86 results:
1. TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to MYH9.
Hu R; Cao Y; Wang Y; Zhao T; Yang K; Fan M; Guan M; Hou Y; Ying J; Ma X; Deng N; Sun X; Zhang Y; Zhang X
Breast Cancer Res; 2024 Mar; 26(1):48. PubMed ID: 38504374
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic significance of alveolar collapse in lung invasive adenocarcinoma and its relationship with tumor infiltrating lymphocytes.
Shen Y; Li L; Yang Z; Wen Y; Qian L; He H
Pathol Res Pract; 2024 Feb; 254():155149. PubMed ID: 38277751
[TBL] [Abstract] [Full Text] [Related]
3. Neutrophil infiltration associated genes on the prognosis and tumor immune microenvironment of lung adenocarcinoma.
Liu R; Zhu G; Sun Y; Li M; Hu Z; Cao P; Li X; Song Z; Chen J
Front Immunol; 2023; 14():1304529. PubMed ID: 38204755
[TBL] [Abstract] [Full Text] [Related]
4. Identification and prognostic biomarkers among ZDHHC4/12/18/24, and APT2 in lung adenocarcinoma.
Bian J; Xiong W; Yang Z; Li M; Song D; Zhang Y; Liu C
Sci Rep; 2024 Jan; 14(1):522. PubMed ID: 38177255
[TBL] [Abstract] [Full Text] [Related]
5. cd95 promotes stemness of colorectal cancer cells by lncRNA MALAT1.
Gao C; Jia K; Fang J; Zhu X; Hu J; Zhang Y; Jiang J; Yu X; Wang D; Gu H; Chen Z
Life Sci; 2024 Feb; 338():122394. PubMed ID: 38159593
[TBL] [Abstract] [Full Text] [Related]
6. High Expression of fas-Associated Factor 1 Indicates a Poor prognosis in Non-Small-Cell lung cancer.
Hu D; Yamada H; Yoshimura K; Ohta T; Tsuchiya K; Inoue Y; Funai K; Suda T; Iwashita Y; Watanabe T; Ogawa H; Kurono N; Shinmura K; Sugimura H
Curr Oncol; 2023 Oct; 30(11):9484-9500. PubMed ID: 37999107
[TBL] [Abstract] [Full Text] [Related]
7. Identifying prognostic genes related PANoptosis in lung adenocarcinoma and developing prediction model based on bioinformatics analysis.
Zhang C; Xia J; Liu X; Li Z; Gao T; Zhou T; Hu K
Sci Rep; 2023 Oct; 13(1):17956. PubMed ID: 37864090
[TBL] [Abstract] [Full Text] [Related]
8. Inflammation index predicts radiation-induced lung injury and prognosis in lung tumors treated with stereotactic body radiation therapy.
Shan J; Xie X; Gu B; Sun X; Liu H
Jpn J Radiol; 2024 Jan; 42(1):102-108. PubMed ID: 37684513
[TBL] [Abstract] [Full Text] [Related]
9. BCKDK regulates breast cancer cell adhesion and tumor metastasis by inhibiting TRIM21 ubiquitinate talin1.
Xu C; Yang K; Xuan Z; Li J; Liu Y; Zhao Y; Zheng Z; Bai Y; Shi Z; Shao C; Zhang L; Sun H
Cell Death Dis; 2023 Jul; 14(7):445. PubMed ID: 37460470
[TBL] [Abstract] [Full Text] [Related]
10. Interleukin 8 in plasma is an efficacy marker for advanced non-small cell lung cancer treated with hypofractionated radiotherapy and PD-1 blockade.
Kang P; Liu D; Li L; Guo X; Ye Y; Li Y; Jiang Q; Lin S; Yuan Q
Cytokine; 2023 Mar; 163():156133. PubMed ID: 36724715
[TBL] [Abstract] [Full Text] [Related]
11. The interaction of CFLAR with p130Cas promotes cell migration.
Li H; Li L; Qiu X; Zhang J; Hua Z
Biochim Biophys Acta Mol Cell Res; 2023 Feb; 1870(2):119390. PubMed ID: 36400248
[TBL] [Abstract] [Full Text] [Related]
12. A single center analysis of first-line treatment in advanced KRAS mutant non-small cell lung cancer: real-world practice.
Liu Y; Gao Y; Wang Y; Zhao C; Zhang Z; Li B; Zhang T
BMC Cancer; 2022 Nov; 22(1):1175. PubMed ID: 36376839
[TBL] [Abstract] [Full Text] [Related]
13. lung carcinoid tumours: histology and Ki-67, the eternal rivalry.
Centonze G; Maisonneuve P; Simbolo M; Lagano V; Grillo F; Fabbri A; Prinzi N; Garzone G; Filugelli M; Pardo C; Mietta A; Pusceddu S; Sabella G; Bercich L; Mangogna A; Rolli L; Grisanti S; Benvenuti MR; Pastorino U; Roz L; Scarpa A; Berruti A; Capella C; Milione M
Histopathology; 2023 Jan; 82(2):324-339. PubMed ID: 36239545
[TBL] [Abstract] [Full Text] [Related]
14. Establishment and Validation of a Machine Learning Prediction Model Based on Big Data for Predicting the Risk of Bone Metastasis in Renal Cell Carcinoma Patients.
Xu C; Liu W; Yin C; Li W; Liu J; Sheng W; Tang H; Li W; Zhang Q
Comput Math Methods Med; 2022; 2022():5676570. PubMed ID: 36226243
[TBL] [Abstract] [Full Text] [Related]
15. Wedge Resection vs Lobectomy for Clinical Stage IA Non-Small Cell lung cancer With Occult Lymph Node Disease.
Kneuertz PJ; Abdel-Rasoul M; D'Souza DM; Moffatt-Bruce SD; Merritt RE
Ann Thorac Surg; 2023 Jun; 115(6):1344-1351. PubMed ID: 36126718
[TBL] [Abstract] [Full Text] [Related]
16. Elevated air quality index and fine particulate matter levels contribute to the poor prognosis and progression of nonsmall-cell lung cancer: A cohort study combined with external validation.
Li J; Wei X; Gu L; Qiu L; Xiang M; Zhang H; Xia L; Pan W; Yang Z; Zhou X; Zeng D; Jiang J
Cancer Med; 2022 Sep; 11(17):3272-3281. PubMed ID: 35312179
[TBL] [Abstract] [Full Text] [Related]
17. A novel 14-gene signature for overall survival in lung adenocarcinoma based on the Bayesian hierarchical Cox proportional hazards model.
Sun N; Chu J; Hu W; Chen X; Yi N; Shen Y
Sci Rep; 2022 Jan; 12(1):27. PubMed ID: 34996932
[TBL] [Abstract] [Full Text] [Related]
18. Postoperative Empyema After Pleurectomy Decortication for Malignant Pleural Mesothelioma.
Lapidot M; Mazzola E; Freyaldenhoven S; De León LE; Jaklitsch MT; Bueno R
Ann Thorac Surg; 2022 Oct; 114(4):1214-1219. PubMed ID: 34619137
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic Value of Uncertain Resection for Overall Survival in Non-small Cell lung cancer.
Kadomatsu Y; Nakamura S; Ueno H; Goto M; Ozeki N; Fukumoto K; Fukui T; Suzuki Y; Chen-Yoshikawa TF
Ann Thorac Surg; 2022 Oct; 114(4):1262-1268. PubMed ID: 34474024
[TBL] [Abstract] [Full Text] [Related]
20. ACSL family: The regulatory mechanisms and therapeutic implications in cancer.
Quan J; Bode AM; Luo X
Eur J Pharmacol; 2021 Oct; 909():174397. PubMed ID: 34332918
[TBL] [Abstract] [Full Text] [Related]
[Next]
